Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia.
暂无分享,去创建一个
[1] S. Ekker,et al. Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.
[2] P. Gillette,et al. Atrioventricular block in a new born with acquired long QT syndrome , 2001, Cardiology in the Young.
[3] A. Sajantila,et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. , 2000, Journal of the American College of Cardiology.
[4] M. Fishman,et al. FROM ZEBRAFISH TO HUMAN , 2002 .
[5] M. Yamamoto,et al. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[6] U. Langheinrich,et al. Zebrafish: a new model on the pharmaceutical catwalk. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[7] B Attali,et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes , 1997, British journal of pharmacology.
[8] F. Lang,et al. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole , 1996, FEBS letters.
[9] E. Green,et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.
[10] Alan L. Clark,et al. Astemizole-induced ventricular arrhythmias: an unexpected cause of convulsions. , 1991, International journal of cardiology.
[11] U. Langheinrich,et al. Zebrafish as a Model Organism for the Identification and Characterization of Drugs and Genes Affecting p53 Signaling , 2002, Current Biology.
[12] T. Colatsky,et al. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. , 1998, Circulation research.
[13] J. Towbin,et al. Molecular biology and the prolonged QT syndromes. , 2001, The American journal of medicine.
[14] C. Nüsslein-Volhard,et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. , 1996, Development.
[15] Martin Borggrefe,et al. Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.
[16] H. Duff,et al. Age-dependent response of the electrocardiogram to K(+) channel blockers in mice. , 2000, American journal of physiology. Cell physiology.
[17] C. Liao,et al. Zebrafish M2 muscarinic acetylcholine receptor: cloning, pharmacological characterization, expression patterns and roles in embryonic bradycardia , 2002, British journal of pharmacology.
[18] D. Rampe,et al. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. , 2000, European journal of pharmacology.
[19] Cavero,et al. QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. , 1999, Pharmaceutical science & technology today.
[20] C. January,et al. Droperidol Lengthens Cardiac Repolarization due to Block of the Rapid Component of the Delayed Rectifier Potassium Current , 1999, Journal of cardiovascular electrophysiology.
[21] Jun Chen,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] T J Campbell,et al. HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.
[23] Gea-Ny Tseng,et al. IKr: The hERG Channel , 2001 .
[24] M. Hofbeck,et al. Fetal sinus bradycardia and the long QT syndrome. , 2001, American journal of obstetrics and gynecology.
[25] Y Horio,et al. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel. , 1999, European journal of pharmacology.
[26] E. Marbán,et al. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Drolet,et al. Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. , 1999, The Journal of pharmacology and experimental therapeutics.
[28] M. Horie,et al. Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG. , 2001, American journal of medical genetics.
[29] M. Fishman,et al. From Zebrafish to human: modular medical models. , 2002, Annual review of genomics and human genetics.
[30] C. Ponting,et al. PAS: a multifunctional domain family comes to light , 1997, Current Biology.
[31] A. Brown,et al. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG , 1997, FEBS letters.
[32] G. Gintant,et al. The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced Arrhythmogenesis , 2001, Journal of cardiovascular pharmacology.
[33] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[34] Maurizio Recanatini,et al. Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes , 2002, Drug safety.
[35] Calum A. MacRae,et al. Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.
[36] A. Wilde,et al. Homozygous premature truncation of the HERG protein : the human HERG knockout. , 1999, Circulation.
[37] C. Wiley,et al. Cardiotoxic effects of astemizole overdose in children. , 1992, The Journal of pediatrics.
[38] L. Annunziato,et al. Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications. , 1998, Biochemical Pharmacology.